Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Want an HSA/FSA-Friendly GLP-1 Program
Retatrutide, a once-weekly injection, makes the body more efficient at regulating appetite, digestion, and energy expenditure by activating these three receptors: Glucose-dependent insulinotropic polypeptide (GIP) Glucagon-like peptide 1 (GLP-1) Glucagon (GCG) Phase-2 clinical trial data published in the New England Journal of Medicine showed that the drug is effective for weight loss
This can create dangerous gaps in care, especially for individuals managing type 2 diabetes
OPRAH JOINS WAVE OF CELEBRITIES WHO REVEALED DRAMATIC WEIGHT LOSS IN 2025 A daily 25 mg pill version of Novo Nordisk's Wegovy, a semaglutide designed to treat obesity, is now approved and available for chronic weight management, offering a non-injectable option for some patients
According to FDA prescribing information, nausea occurs in 15-44% of patients depending on the specific agent and dose, with vomiting affecting 5-24% and constipation occurring in 10-24% of users
US$ 20.94
US$ 22.31
US$ 26.53
US$ 25.73
US$ 24.12
US$ 24.54
